Oxeia Biopharmaceuticals Oversubscribes First Crowdfunding Campaign, Extends Round for New Investors
Concussion therapeutics developer surpasses crowdfunding goal reflecting strong investor interest in its clinical-stage ghrelin therapy for persistent symptoms. BOSTON, MA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Oxeia …